From Blood Plasma to Drugs
Blood saves life - in many ways.
The manufacture of pharmaceutical products from blood plasma by plasma fractionation requires process conditions that are extremely kind to the product. These products are manufactured under sterile conditions that require materials and processing of the highest quality. In addition, the process has to comply with a large number of national and international standards and statutory provisions.
Manufacturers, therefore, expect great precision in the manufacture and assembly of their process plants. Every detail of the design must comply with high-quality standard to avoid production errors. Using high-performance processing equipment helps guarantee reliable production.
All Production Steps from one Source
As a competent manufacturer of complete plants for the pharmaceutical industry, GEA Diessel offers you full service to meet every specification. From the planning, development and installation of your new process plant all the way to qualification and maintenance - our experienced engineers will work with your project team to develop innovative and efficient process technologies for your very individual blood plasma processing applications.
Performance and Quality
Whatever it is you need your process plant for: the fractionation and manufacture of products from immunoglobulins, human albumins, Factor VIII, Factor IX or whatever - our wide range of plant concepts will provide the equipment you need to meet any requirements or conditions.
By using the most advanced manufacturing concepts for vessels and skids and the latest components and valve technology, we ensure that your plant manufactures your products economically and in a way that´s kind to the source materials too.
For detailed information please refer to our brochure "Process plant for pharmaceutical and biotechnology industries".